TEL AVIV, Israel – It's long been known that academia and industry, two key actors in the development of new products for the medical technology and biotechnology sectors, have very different priorities and approaches to research and products. The ongoing effort to bridge the gap between those differences to eliminate waste in the system and develop more new and efficient products was a key focus of the MIXiii Biomed conference this week.